<SEC-DOCUMENT>0001104659-21-097779.txt : 20210730
<SEC-HEADER>0001104659-21-097779.hdr.sgml : 20210730
<ACCEPTANCE-DATETIME>20210729194550
ACCESSION NUMBER:		0001104659-21-097779
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210728
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210730
DATE AS OF CHANGE:		20210729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Liberty Media Corp
		CENTRAL INDEX KEY:			0001560385
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEVISION BROADCASTING STATIONS [4833]
		IRS NUMBER:				371699499
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35707
		FILM NUMBER:		211129365

	BUSINESS ADDRESS:	
		STREET 1:		12300 LIBERTY BOULEVARD
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		720-875-5400

	MAIL ADDRESS:	
		STREET 1:		12300 LIBERTY BOULEVARD
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Liberty Spinco, Inc.
		DATE OF NAME CHANGE:	20121015
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2123478d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:lmca="http://libertymedia.com/20210728">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_lmca_libertymedia.com_20210728 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20210728_20210728 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001560385 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityCentralIndexKey">0001560385</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lmca-20210728.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-07-28to2021-07-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySiriusXmGroupCommonClassMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySiriusXmGroupCommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySirusXmGroupCommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyBravesGroupCommonClassMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyBravesGroupCommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyFormulaOneGroupCommonClassMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001560385</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyFormulaOneGroupCommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">UNITED STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt"><b>FORM <span id="xdx_907_edei--DocumentType_c20210728__20210728_zlhAaTjsuRLh"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">Pursuant
to Section 13 or 15(d)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">of the Securities
Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 11pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">Date of Report
(date of earliest event reported): <b><span id="xdx_902_edei--DocumentPeriodEndDate_c20210728__20210728_z9w9u16M5SN"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 28, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20210728__20210728_zo9otLyQ951c"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityRegistrantName">LIBERTY
MEDIA CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt">(Exact name
of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 32%; font-size: 10pt; color: #000000; font-weight: bold; text-align: center; padding-bottom: 1pt"><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20210728__20210728_zOjMhDqToKH7"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td><td style="width: 2%; font-size: 10pt; color: #000000; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="width: 32%; font-size: 10pt; color: #000000; font-weight: bold; text-align: center; padding-bottom: 1pt"><span id="xdx_90C_edei--EntityFileNumber_c20210728__20210728_zG6geqVDQki3"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityFileNumber">001-35707</ix:nonNumeric></span></td><td style="width: 2%; font-size: 10pt; color: #000000; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="width: 32%; font-size: 10pt; color: #000000; font-weight: bold; text-align: center; padding-bottom: 1pt"><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20210728__20210728_zyVfWcbOeGw4"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityTaxIdentificationNumber">37-1699499</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(State or other jurisdiction of <br />incorporation or organization)</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt"><p style="margin-top: 0; margin-bottom: 0">(Commission
<br />File Number)</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt"><p style="margin-top: 0; margin-bottom: 0">(I.R.S.
Employer <br />Identification No.)</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20210728__20210728_z1GfXmKkABb9"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityAddressAddressLine1">12300 Liberty Blvd.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20210728__20210728_zjG1VHjYiMg4"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityAddressCityOrTown">Englewood</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20210728__20210728_zqGVfKGG26xh"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20210728__20210728_zTZlbcTX12G9"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices
and zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant's telephone number, including
area code: <b>(<span id="xdx_901_edei--CityAreaCode_c20210728__20210728_zwO9LNCKiWcb"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:CityAreaCode">720</ix:nonNumeric></span>) <span id="xdx_90C_edei--LocalPhoneNumber_c20210728__20210728_z3fm5qkA9SUf"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" name="dei:LocalPhoneNumber">875-5400</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20210728__20210728_z5kUipqWkrVa"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_901_edei--SolicitingMaterial_c20210728__20210728_zQvoHv9v5c4k"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20210728__20210728_zyCLK1FYpWS9"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20210728__20210728_zMunoUX6YvXg"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 6pt; text-align: center; width: 41%"><span style="font-size: 10pt">Title of each class </span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; text-align: center; width: 20%"><span style="font-size: 10pt">Trading symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-bottom: 6pt; text-align: center; width: 39%"><span style="font-size: 10pt">Name of each exchange on which registered </span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassMember_zxE2tr4lGDsh"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember" name="dei:Security12bTitle">Series A Liberty SiriusXM Common Stock</ix:nonNumeric></span> </span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassMember_zmhstjnSUiE7"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember" name="dei:TradingSymbol">LSXMA</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassMember_zF1HU8zr42O8"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassBMember_zsgI8paUhG5"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember" name="dei:Security12bTitle">Series B Liberty SiriusXM Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassBMember_zUaiT2AaNR43"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember" name="dei:TradingSymbol">LSXMB</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySiriusXmGroupCommonClassBMember_zfL3RRjAwIN"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySirusXmGroupCommonClassCMember_z4swToZcFYH6"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember" name="dei:Security12bTitle">Series C Liberty SiriusXM Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySirusXmGroupCommonClassCMember_z6MUlcM3ytyf"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember" name="dei:TradingSymbol">LSXMK</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertySirusXmGroupCommonClassCMember_z0E0mTdKWiY5"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassMember_zT78zYyH9dX2"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember" name="dei:Security12bTitle">Series A Liberty Braves Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassMember_zdeKr2hLBq09"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember" name="dei:TradingSymbol">BATRA</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassMember_zIkL4mz19sH7"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassCMember_zija6VGS2glj"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember" name="dei:Security12bTitle">Series C Liberty Braves Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassCMember_z3WNxW52n2Ol"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember" name="dei:TradingSymbol">BATRK</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyBravesGroupCommonClassCMember_z1RlqrdJXMwc"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassMember_zvCxZ2OtMymk"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember" name="dei:Security12bTitle">Series A Liberty Formula One Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassMember_zGKN2Yiqglc1"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember" name="dei:TradingSymbol">FWONA</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassMember_zzzDRmjNpHNg"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: middle">
    <td style="border: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassCMember_zkMKtuTxrhVc"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember" name="dei:Security12bTitle">Series C Liberty Formula One Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassCMember_zc4GcjgBJYOc"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember" name="dei:TradingSymbol">FWONK</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20210728__20210728__us-gaap--StatementClassOfStockAxis__custom--LibertyFormulaOneGroupCommonClassCMember_z19s4wVMUeJg"><ix:nonNumeric contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#160; <span style="font-family: Wingdings"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20210728__20210728_zFNajBPjZR81"><ix:nonNumeric contextRef="From2021-07-28to2021-07-28" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160; <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">On July </span>28,
2021, Liberty Media Corporation (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) entered into an Exchange Agreement (as defined below) with its Chairman
of the Board, John C. Malone, whereby, among other things, Mr. Malone agreed to an arrangement under which his aggregate voting power
in the Company would not exceed 49% (the &#8220;<span style="text-decoration: underline">Target Voting Power</span>&#8221;) plus 0.5% (under certain circumstances). As of June
30, 2021, Mr. Malone beneficially owned shares of common stock of the Company constituting approximately 48.6% of the aggregate outstanding
voting power of the Company, including approximately 47.5%, 47.6% and 49.0% of the outstanding voting power of the Company&#8217;s Braves
Group tracking stock, Formula One Group tracking stock and Liberty SiriusXM Group tracking stock, respectively. The Company has an ongoing
stock repurchase program which permits the Company to purchase shares of Series A or Series C of any of <span style="background-color: white">the
Company&#8217;s Liberty SiriusXM Group common stock, Braves Group common stock and Formula One Group common stock. In light of Mr. Malone&#8217;s
current ownership interests in the Company, absent the Exchange Agreement, continued r</span>epurchases of the Company&#8217;s Series
A shares pursuant to this program would be expected to have the effect of increasing Mr. Malone&#8217;s aggregate voting power in the
Company to greater than 50%. The Company and its board of directors (the &#8220;<span style="text-decoration: underline">Board</span>&#8221;) believe it is in the best interests
of the Company and its stockholders to not have a single stockholder control greater than 50% of its aggregate voting power and to maintain
flexibility with respect to future share repurchases and other transactions that may have an accretive voting power effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A special committee of independent and disinterested
directors was formed by the Board to consider a potential exchange arrangement between the Company and Mr. Malone and engaged independent
legal counsel and financial advisors to assist it. The special committee recommended to the Board the approval of an exchange agreement,
among the Company, Mr. Malone and a revocable trust of which Mr.&#160;Malone is the sole trustee and beneficiary (the &#8220;<span style="text-decoration: underline">JM Trust</span>&#8221;)
(the &#8220;<span style="text-decoration: underline">Exchange Agreement</span>&#8221;). The Board, upon the unanimous recommendation of the members of the special committee, approved
the Exchange Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i><span style="text-decoration: underline">Exchange Agreement</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Exchange Agreement provides for exchanges by
the Company and Mr. Malone or the JM Trust of shares of Series B Liberty SiriusXM common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series
B Liberty SiriusXM Common Stock</span>&#8221;), Series B Liberty Braves common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series B Liberty
Braves Common Stock</span>&#8221;), or Series B Liberty Formula One common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series B Liberty
Formula One Common Stock</span>&#8221;), for shares of Series C Liberty SiriusXM common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series
C Liberty SiriusXM Common Stock</span>&#8221;), Series C Liberty Braves common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series C Liberty
Braves Common Stock</span>&#8221;), or Series C Liberty Formula One common stock, par value $0.01 per share (the &#8220;<span style="text-decoration: underline">Series C Liberty
Formula One Common Stock</span>&#8221;), respectively, in connection with certain events, as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Accretive Event Exchange. </i> In connection
with any event that would result in a reduction in the outstanding votes of any of the Company&#8217;s tracking stock groups (each, a
&#8220;<span style="text-decoration: underline">Group</span>&#8221;) or an increase of Mr. Malone&#8217;s beneficially-owned voting power in any Group (other than a Voting Power
Exchange (as defined below)) (an &#8220;<span style="text-decoration: underline">Accretive Event</span>&#8221;), in each case, such that Mr. Malone&#8217;s voting power with respect
to such Group would exceed the Target Voting Power plus 0.5%, Mr. Malone or the JM Trust will be required to exchange with the Company
shares of Series B common stock of such Group (&#8220;<span style="text-decoration: underline">Exchanged Group Series B Shares</span>&#8221;) for an equal number of shares of
Series C common stock of the same Group so as to maintain Mr. Malone&#8217;s voting power with respect to such Group as close as possible
to, without exceeding, the Target Voting Power, on the terms and subject to the conditions of the Exchange Agreement. For example, repurchases
by the Company <span style="background-color: white">of shares of its capital stock, conversions of Series B shares of a Group into Series
A shares of such Group, as well as purchases by Mr. Malone of the Company&#8217;s capital stock, in each case, having the effect on Mr.
Malone&#8217;s voting power described above would be Accretive Events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Dilutive Event Exchange. </i>From and after
the occurrence of any Accretive Event, in connection with any event that would result in an increase in the outstanding votes of any Group
or a decrease of Mr. Malone&#8217;s beneficially-owned voting power in any Group (a &#8220;<span style="text-decoration: underline">Dilutive Event</span>&#8221;), in each case,
such that Mr. Malone&#8217;s voting power with respect to such Group falls below the Target Voting Power less 0.5%, Mr. Malone and the
JM Trust may exchange with the Company shares of Series C common stock of a Group for an equal number of shares of Series B common stock
of the same Group equal to the lesser of (i) the number of shares of Series B common stock of the same Group which would maintain Mr.
Malone&#8217;s voting power with respect to such Group as close as possible to, without exceeding, the Target Voting Power and (ii) the
number of Exchanged Group Series B Shares at such time, on the terms and subject to the conditions of the Exchange Agreement. For example,
exercises of stock options for, conversions of convertible securities into or issuances of new shares of <span style="background-color: white">the
Company&#8217;s voting stock having the effect on Mr. Malone&#8217;s voting power described above would be Dilutive Events</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Voting Power Exchange</i>. On a quarterly basis
or in connection with any annual or special meeting of stockholders, if Mr. Malone&#8217;s aggregate voting power in the Company is less
than the Target Voting Power and would continue to be less than the Target Voting Power upon completion of a Voting Power Exchange, upon
request by Mr. Malone or the JM Trust, the Company will be required to exchange with Mr. Malone and the JM Trust shares of Series B common
stock of any Group on a one-for-one basis for shares of Series C common stock of the same Group (each such exchange, a &#8220;<span style="text-decoration: underline">Voting
Power Exchange</span>&#8221;). The maximum number of shares that may be delivered to Mr. Malone or the JM Trust in any Voting Power Exchange
is equal to the number of Exchanged Group Series B Shares at such time that may be delivered without resulting in Mr. Malone&#8217;s aggregate
voting power in the Company exceeding the Target Voting Power. If any Voting Power Exchange would result in Mr. Malone&#8217;s voting
power with respect to any Group exceeding the Target Voting Power, on any matter submitted by the Company to the stockholders of that
Group, voting together as a separate class, for approval, Mr. Malone and the JM Trust will vote, or cause to be voted, the portion of
their voting power of such Group that exceeds the Target Voting Power in the same manner and in the same proportion as voted by the holders
of voting securities of that Group other than Mr. Malone and his controlled affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Fundamental Event Exchange</i>. If the Company
proposes to consummate any combination, consolidation, merger, exchange offer, split-off, spin-off, rights offering or dividend, in each
case, as a result of which holders of Series B common stock of one or more Groups are entitled to receive securities of the Company, securities
of another person, property or cash, or a combination thereof (a &#8220;<span style="text-decoration: underline">Fundamental Event</span>&#8221;) then, unless the consideration
to be received by holders of Series B common stock and Series C common stock of such Group is identical, either (x)&#160;the Company will
provide for Mr.&#160;Malone or the JM Trust to receive, in respect of each Group, as applicable, the same per share amount and form of
consideration to be received by holders of Series B common stock of such Group in connection with such event for each Exchanged Group
Series C Share (defined below) of the same Group or (y) immediately prior to the consummation of the Fundamental Event, the Company will
deliver to Mr.&#160;Malone and the JM Trust all Exchanged Group Series B Shares in exchange for all Exchanged Group Series C Shares. &#8220;<span style="text-decoration: underline">Exchanged
Group Series C Shares</span>&#8221; means the number of shares of Series C common stock of any Group then beneficially owned by Mr. Malone
equal to the number of Exchanged Group Series B Shares of the same Group. In connection with certain Fundamental Events where Mr. Malone
would beneficially own 40% or more of the aggregate voting power of the surviving or resulting company and serve as an officer or director,
such company and Mr. Malone will negotiate an agreement to replicate the benefits and obligations of the Exchange Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Restriction on Transfer</i>. Mr. Malone may
transfer his rights to the Exchanged Group Series B Shares only in limited circumstances and only to certain related permitted transferees
who sign an agreement replicating the benefits and obligations of the Exchange Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Termination</i>. The Exchange Agreement will
terminate with respect to any particular Group upon (i)&#160;the parties&#8217; mutual consent, (ii)&#160;the execution of a successor
exchange agreement between the Company and one or more proposed permitted transferees covering all shares of Series B common stock of
such Group then beneficially owned by Mr. Malone and all Exchanged Group Series B Shares of such Group or (iii) Mr. Malone&#8217;s voting
power in such Group falling below 20%. In addition, the Exchange Agreement will terminate in its entirety, upon (i) the parties&#8217;
mutual consent, (ii) the execution of a successor exchange agreement between the Company and one or more proposed permitted transferees
covering all shares of the Company&#8217;s Series B common stock then beneficially owned by Mr. Malone and all Exchanged Group Series
B Shares or (iii) Mr. Malone&#8217;s aggregate voting power in the Company falling below 20%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Expenses</i>. Under the Exchange Agreement,
the Company has agreed to pay (or reimburse) Mr. Malone for all reasonable out-of-pocket costs and expenses incurred by Mr. Malone in
connection with the preparation, negotiation, execution and consummation of the transactions contemplated by the Exchange Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing description of the Exchange Agreement
does not purport to be complete and is subject to, and is qualified in its entirety by, the Exchange Agreement, a copy of which is attached
hereto as Exhibit 10.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
information provided in Item 1.01 of this Current Report on Form&#160;8-K is incorporated herein by reference. The shares of </span>Series
B Liberty SiriusXM Common Stock, Series B Liberty Braves Common Stock, Series B Liberty Formula One Common Stock, Series C Liberty SiriusXM
Common Stock, Series C Liberty Braves Common Stock and Series C Liberty Formula One Common Stock to be <span style="background-color: white">issued
by the Company pursuant to the Exchange Agreement will not be registered under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221;), in reliance on the exemption from registration under Section&#160;4(a)(2)&#160;of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 13%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 2%; padding-right: 3pt; padding-bottom: 2pt; padding-left: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 85%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2123478d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 3pt; padding-bottom: 2pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm2123478d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Exchange Agreement, dated as of July 28, 2021, by and among John C. Malone, the John C. Malone 1995 Revocable Trust U/A DTD 3/6/1995 and Liberty Media Corporation.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; padding-right: 3pt; padding-bottom: 2pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Date:
July 29, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt; width: 50%">&#160;</td>
  <td style="padding-left: 10pt; text-indent: -10pt; width: 50%">LIBERTY MEDIA CORPORATION</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%"></td><td style="width: 3%; text-align: left">By:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Brittany A. Uthoff</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">Name: Brittany A. Uthoff</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">Title: Vice President</td></tr>
     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 279pt; text-indent: -27pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJylj9FqwjAUhp+g73DotWjiELbezaIyVrfRyfA21uMIa3LKSerWR9pbLqaM3ShDDYEQ/v//zn/SdJAuaK5rZFhPywJWaJpaeYQSd8hoKwyO/OExg/CW+K6dZ2V9/P4GcwoZDJnJUGyqIETrXjvcZiBuR0KO5B0ImUkB98s0Oeg52Z3eovVa1aDsFl6YGtboFXc9YaW+yJLp4qg3ZKfJZiCHope/YSzkGJ5orz6JPxwURZ4mg3iSdMHUNocxrfNkYFajCbNcH/27sUoVPVmhN8i+e9WsW7c2kRA2M2TzWjm3RBP0YBdifCPkZHYpaHoJ6RgoPxs0ZbVHd/VmxzHn15kTm7ZWzxavrnQa9V+tH+Fd5a0= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2123478d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution Version</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXCHANGE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Exchange Agreement (this &ldquo;<U>Agreement</U>&rdquo;)
is made and entered into as of July 28, 2021, by and among John C. Malone (&ldquo;<U>Dr. Malone</U>&rdquo;), the John C. Malone 1995
Revocable Trust U/A DTD 3/6/1995 (the &ldquo;<U>Trust</U>&rdquo;) and Liberty Media Corporation, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as of June 30, 2021, Dr. Malone beneficially
owns shares of Common Stock constituting approximately 48.6% of the outstanding voting power of the Company and approximately 47.5%, 47.6%
and 49.0% of the outstanding voting power of the Braves Group, the Formula One Group and the Sirius XM Group, respectively; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company and Dr. Malone have agreed
to enter into the arrangements contemplated by this Agreement in light of, among other things, the fact that the Malone Voting Power in
reference to each Group and the Company could become a majority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the covenants
and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Accretive Event Notice</U>&rdquo; has
the meaning set forth in <U>Section 3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Accretive Event</U>&rdquo; means, with
respect to the Voting Securities of a Group, any event resulting in (i) the decrease of the Outstanding Votes of such Group, whether by
repurchase, redemption, conversion of the Voting Securities of such Group (including any conversion of shares of Series B Common Stock
of such Group into shares of Series A Common Stock of such Group) or otherwise or (ii) Dr. Malone&rsquo;s beneficial ownership of Voting
Securities of such Group increasing (excluding through a Voting Power Exchange), in either case, without duplication and immediately following
which, and after taking into account any concurrent or substantially concurrent other event resulting in (a) the effects described in
clauses (i) or (ii) above, (b) the effects described in clause (i) or (ii) of the definition of Dilutive Event or (c) a Fundamental Event,
the Malone Voting Power with respect to such Group would be greater than 0.5% <U>plus</U> the Target Voting Power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo; means any claim, audit,
action, suit, proceeding, arbitration, mediation or investigation by or before any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo; means, with respect
to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under
common control with such specified Person, for so long as such Person remains so affiliated to the specified Person. For purposes of this
definition, and for the avoidance of doubt, natural persons shall not be deemed to be Affiliates of each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Agreement</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Available Series B Shares</U>&rdquo;
means, with respect to a Group, at the time of any determination thereof, a number of shares of Series B Common Stock of such Group equal
to (x) the aggregate number of Reverse Exchange Shares of such Group delivered to the Company at any one or more Reverse Exchange Closings
occurring prior to such time of determination, <U>minus</U> (y) the aggregate number of shares of Series B Common Stock of such Group
delivered to Dr. Malone or the Trust at any one or more prior Dilutive Event Exchange Closings, Fundamental Event Exchange Closings, or
Voting Power Exchange Closings occurring prior to such time of determination. For the avoidance of doubt, there are no Available Series
B Shares of any Group as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>beneficial owner</U>&rdquo;, &ldquo;<U>beneficial
ownership</U>&rdquo; and &ldquo;<U>beneficially owns</U>&rdquo; have the meanings given to such terms in Rule 13d-3 under the Exchange
Act, and beneficial ownership of capital stock or any other equity security which is then entitled to vote generally in the election of
directors shall be calculated in accordance with the provisions of such Rule; provided, however, that, for purposes of determining beneficial
ownership, (a) in respect of Dr. Malone or any Proposed Transferee, such Person shall be deemed to be the beneficial owner of any Equity
which may be acquired by such Person (disregarding any conditions or legal impediments to such beneficial ownership), whether within sixty
(60) days or thereafter, upon the conversion, exchange or exercise of any warrants, options, rights or other securities, (b) notwithstanding
clause (a), none of Dr. Malone or any Proposed Transferee shall be deemed to beneficially own any Available Series B Shares unless and
until Dr. Malone or such Proposed Transferee, as applicable, acquires such shares at an Exchange Closing pursuant to the terms of this
Agreement, and Dr. Malone will cease to beneficially own any shares of Series B Common Stock upon delivery of such shares to the Company
at any Reverse Exchange Closing, (c) notwithstanding clause (a), Dr. Malone shall not be deemed to beneficially own any shares of Series
A Common Stock into which any shares of Series B Common Stock beneficially owned by Dr. Malone may be converted pursuant to the Company
Charter, (d) Dr. Malone shall not be deemed to beneficially own any Equity solely as a result of Dr. Malone&rsquo;s execution of this
Agreement or Dr. Malone&rsquo;s filing of any reports, forms or schedules with the SEC or other Governmental Authority in connection with
any of the matters contemplated hereby, (e) Dr. Malone and any Proposed Transferee shall be deemed, respectively, to beneficially own
any Voting Securities beneficially owned by any respective Controlled Affiliate of such Person, and (f) notwithstanding clause (b) above,
a Proposed Transferee shall be deemed to beneficially own, any Available Series B Shares that would be the subject of any Successor Exchange
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Board</U>&rdquo; means the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Braves Group</U>&rdquo; shall have the
meaning ascribed thereto in the Company Charter as of the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo; means any day
that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in the City of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Code</U>&rdquo; means the Internal Revenue
Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo; means any or
all Common Stock of the Company designated as such in the Company Charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Company</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Company Bylaws</U>&rdquo; means the Bylaws
of the Company, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Company Charter</U>&rdquo; means the
Restated Certificate of Incorporation of the Company, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Company Exchange Shares</U>&rdquo; means
(i) any shares of Series C Common Stock issued and/or delivered in a Reverse Exchange and (ii) any Available Series B Shares issued and/or
delivered in a Dilutive Event Exchange, Fundamental Event Exchange or Voting Power Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Company Rescission Shares</U>&rdquo;
shall have the meaning set forth in <U>Section 6(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Competition Law</U>&rdquo; means any
Law that is designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or lessening
of competition through merger or acquisition or restraint of trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Controlled Affiliate</U>&rdquo; means
with respect to any Person, any other Person (other than an individual) controlled by such Person. For the purpose of this definition,
the term &ldquo;control&rdquo; (including, with a correlative meaning, the term &ldquo;controlled by&rdquo;), as used with respect to
any Person, means (i) beneficial ownership, directly or indirectly, of securities of any Person that represent more than 50% of the vote
in the election of directors (or equivalent), (ii) otherwise being entitled to nominate or designate, directly or indirectly, a majority
of the directors (or equivalent) or (iii) in the case of a limited partnership or limited liability company, being a general partner or
managing member and having the power to direct the policies, management and affairs of such entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Delaware Courts</U>&rdquo; has the meaning
set forth in <U>Section 15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Dilutive Event</U>&rdquo; means, with
respect to the Voting Securities of a Group, any event resulting in (i) the increase of the Outstanding Votes of such Group, whether upon
the exercise of stock options, conversion of any convertible security, issuance of capital stock or otherwise, or (ii) Dr. Malone&rsquo;s
beneficial ownership of Voting Securities of such Group decreasing, immediately following which, and after taking into account any concurrent
or substantially concurrent other event resulting in (a) the effects described in clauses (i) or (ii) above, (b) the effects described
in clauses (i) or (ii) of the definition of Accretive Event, or (c) a Fundamental Event, the Malone Voting Power in respect of such Group
would be less than the Target Voting Power <U>minus</U> 0.5%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Dilutive Event Exchange</U>&rdquo; has
the meaning set forth in <U>Section 2(d)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Dilutive Event Exchange Closing</U>&rdquo;
has the meaning set forth in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Dilutive Event Notice</U>&rdquo; has
the meaning set forth in <U>Section 2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Dr. Malone</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Encumbrance</U>&rdquo; means any mortgage,
deed of trust, lien (statutory or otherwise), pledge, hypothecation, charge, title retention device, restriction, covenant, title defect,
assignment, adverse claim, encumbrance, option, right of first refusal or first offer, preemptive right or security interest of any kind
or nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any
restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession,
exercise or transfer of any other attribute of ownership of any asset).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Equity</U>&rdquo; means any and all shares
of capital stock and securities issuable upon the conversion, exercise or exchange of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Exchange</U>&rdquo; means a Dilutive
Event Exchange, a Reverse Exchange, a Voting Power Exchange, or a Fundamental Event Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Exchange Closing</U>&rdquo; means a Dilutive
Event Exchange Closing, a Reverse Exchange Closing, a Fundamental Event Exchange Closing or a Voting Power Exchange Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Exchange Event</U>&rdquo; means a Dilutive
Event, an Accretive Event or a Fundamental Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Family Member</U>&rdquo; means a descendant
of a parent of either John C. Malone or Leslie A. Malone, or any trust whose sole beneficiaries are one or more descendants of a parent
of either John C. Malone or Leslie A. Malone and, in the case of a charitable remainder trust, a charitable beneficiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Formula One Group</U>&rdquo; shall have
the meaning ascribed thereto in the Company Charter as of the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Fundamental Event</U>&rdquo; means any
combination, consolidation, merger, exchange offer, split-off, spin-off, rights offering or dividend, in each case, as a result of which
holders of Series B Common Stock of one or more Groups are entitled to receive securities of the Company, securities of another Person,
property or cash, or a combination thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Fundamental Event Exchange</U>&rdquo;
has the meaning set forth in <U>Section 4(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Fundamental Event Exchange Closing</U>&rdquo;
has the meaning set forth in <U>Section 4(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Governmental Authority</U>&rdquo; means
any supranational, national, federal, state, county, local or municipal government, or other political subdivision thereof, or any court,
tribunal or arbitral body and any entity exercising executive, legislative, judicial, regulatory, taxing, administrative, prosecutorial
or arbitral functions of or pertaining to government, domestic or foreign; <I>provided</I>, that such term shall not include any stock
exchange or listing company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Group</U>&rdquo; means, as applicable,
the Sirius XM Group, the Braves Group or the Formula One Group, or any other tracking stock group that may be created from time to time
after the date hereof which is intended to track the performance of a specified group of assets and businesses of the Company. For the
avoidance of doubt, in the event the Company Charter is amended to eliminate the tracking stock capitalization structure of the Company,
the term &ldquo;Group&rdquo; shall refer to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>HSR Act</U>&rdquo; means the Hart-Scott-Rodino
Antitrust Improvements Act of 1976 and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Independent Director</U>&rdquo; means
a member of the Board who (i) qualifies as an &ldquo;Independent Director&rdquo; as defined in the <FONT STYLE="background-color: white">NASDAQ
Marketplace Rules or who qualifies as &ldquo;independent&rdquo; under the applicable rules and regulations of any other </FONT>national
<FONT STYLE="background-color: white">securities exchange on which the Common Stock is publicly traded on or after the date hereof and
(ii) is independent for purposes of Delaware law (as determined in good faith by the Board) from Dr. Malone and, in connection with approval
of a Successor Exchange Agreement, from any counterparties thereto</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Law</U>&rdquo; means all foreign, federal,
state, provincial, local or municipal laws (including common law), statutes, ordinances, regulations and rules of any Governmental Authority,
and all Orders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Malone Rescission Shares</U>&rdquo; shall
have the meaning set forth in <U>Section 6(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Malone Series C Exchangeable Shares</U>&rdquo;
means, with respect to any Group, and at the time of any determination thereof, a number of shares of Series C Common Stock of such Group
equal to the number of Available Series B Shares of such Group at such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Malone Voting Power</U>&rdquo; means,
at the time of any determination thereof, (i) when used in reference to a particular Group, the aggregate voting power of the Voting Securities
of such Group with respect to which Dr. Malone has beneficial ownership as a percentage of the voting power of all outstanding Voting
Securities of such Group and (ii) when used in reference to the Company, the aggregate voting power of the Voting Securities of the Company
with respect to which Dr. Malone has beneficial ownership as a percentage of the voting power of all outstanding Voting Securities of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Maximum Amount</U>&rdquo; has the meaning
set forth in <U>Section 5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Order</U>&rdquo; means any judgment,
order, writ, award, preliminary or permanent injunction or decree of any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Other Voting Securities</U>&rdquo; has
the meaning set forth in <U>Section 5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Outstanding Votes</U>&rdquo; means, at
the time of any determination thereof, and in respect of any Group, the total number of votes that may be cast by the holders of the outstanding
Voting Securities of such Group in their capacity as such at any meeting of stockholders of the Company at which matters generally voted
on by the holders of Voting Securities are to be considered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Permitted Encumbrance</U>&rdquo; means
(i) any Encumbrance under this Agreement (including, without limitation, pursuant to <U>Section 6</U> hereof), and (ii) any restrictions
on Transfer arising under securities Laws of general applicability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means any individual,
corporation, limited liability company, limited or general partnership, joint venture, association, joint-stock company, trust, unincorporated
organization, Governmental Authority or any group comprised of two (2) or more of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Proposed Transferee</U>&rdquo; means
any Family Member or group of Family Members (as group is used in Section 13(d) under the Exchange Act) to whom Dr. Malone (or his executors,
administrators or testamentary trustees) or the Trust proposes to Transfer (or does Transfer) Voting Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Rescission</U>&rdquo; has the meaning
set forth in <U>Section 6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Rescission Exchange</U>&rdquo; has the
meaning set forth in <U>Section 9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Reverse Exchange</U>&rdquo; has the meaning
set forth in <U>Section 3(c)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Reverse Exchange Closing</U>&rdquo; has
the meaning set forth in <U>Section 3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Reverse Exchange Shares</U>&rdquo; has
the meaning set forth in <U>Section 3(c)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>SEC</U>&rdquo; means the United States
Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo; means the Securities
Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Series A Common Stock</U>&rdquo; means
(i) the series of Common Stock designated as &ldquo;Series A Liberty Sirius XM Common Stock&rdquo; in the Company Charter, (ii) the series
of Common Stock designated as &ldquo;Series A Liberty Braves Common Stock&rdquo; in the Company Charter, (iii) the series of Common Stock
designated as &ldquo;Series A Liberty Formula One Common Stock&rdquo; in the Company Charter and (iv) any other series of voting Common
Stock created after the date hereof in respect of a newly created Group the holders of which are generally entitled to the lowest positive
number of votes per share for series of Common Stock with respect to such Group in matters submitted to the stockholders of the Company
for a vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Series B Common Stock</U>&rdquo; means
(i) the series of Common Stock designated as &ldquo;Series B Liberty Sirius XM Common Stock&rdquo; in the Company Charter, (ii) the series
of Common Stock designated as &ldquo;Series B Liberty Braves Common Stock&rdquo; in the Company Charter, (iii) the series of Common Stock
designated as &ldquo;Series B Liberty Formula One Common Stock&rdquo; in the Company Charter and (iv) any other series of voting Common
Stock created after the date hereof in respect of a newly created Group the holders of which are generally entitled to the highest number
of votes per share for series of Common Stock with respect to such Group in matters submitted to the stockholders of the Company for a
vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Series C Common Stock</U>&rdquo; means
(i) the series of Common Stock designated as &ldquo;Series C Liberty Sirius XM Common Stock&rdquo; in the Company Charter, (ii) the series
of Common Stock designated as &ldquo;Series C Liberty Braves Common Stock&rdquo; in the Company Charter, (iii) the series of Common Stock
designated as &ldquo;Series C Liberty Formula One Common Stock&rdquo; in the Company Charter and (iv) any other series of nonvoting Common
Stock created after the date hereof in respect of a newly created Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Sirius XM Group</U>&rdquo; shall have
the meaning ascribed thereto in the Company Charter as of the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Special Committee</U>&rdquo; means any
committee of the Board consisting solely of Independent Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Successor Exchange Agreement</U>&rdquo;
means an exchange agreement between the Company and one or more Proposed Transferees, in substantially the form of this Agreement (as
determined in good faith by a Special Committee or a majority of the Independent Directors) with such modifications as are reasonably
necessary such that if, as of the time of execution of such exchange agreement, such Proposed Transferee&rsquo;s beneficial ownership
of any Group as a percentage of the voting power of all outstanding Voting Securities of such Group is (or would be, after taking into
account the proposed Transfer) greater than the Target Voting Power, such Person agrees to transfer shares of Series B Common Stock of
such Group to the Company in exchange for shares of Series C Common Stock of such Group on a one to one basis so that such Person&rsquo;s
beneficial ownership of shares of such Group as a percentage of the voting power of all outstanding Voting Securities of such Group does
not exceed by more than 0.5% the Target Voting Power of such Group; <I>provided</I> that such transfer requirement may be satisfied, with
respect to any Available Series B Shares subject of such Successor Exchange Agreement, by execution of such Successor Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Surviving Company</U>&rdquo; means the
entity whose securities are received by Dr. Malone or the Trust in a Fundamental Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Target Voting Power</U>&rdquo; means
49.0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Tax</U>&rdquo; or &ldquo;<U>Taxes</U>&rdquo;
means (a) any and all federal, state, local and foreign taxes and other assessments, governmental charges, duties, fees, levies and liabilities
in the nature of a tax, including gross receipts, income, profits, sales, use, occupation, value added, ad valorem, transfer, franchise,
withholding, payroll, recapture, escheat, employment, excise and property taxes and (b) all interest, penalties and additions imposed
with respect to such amounts in clause (a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Tax Return</U>&rdquo; means a report,
return, certificate, form or similar statement or document, including any amendment thereof or any attachment thereto, supplied to or
filed with or required to be supplied to or filed with a Governmental Authority in connection with the determination, assessment or collection
of any Tax, including an information return, claim for refund, amended return or declaration of estimated Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Transfer</U>&rdquo; means a sale, transfer
or disposition of beneficial ownership, directly or indirectly, whether by operation of law or otherwise; <I>provided, however</I>, the
granting of any proxy or the agreement to vote any Voting Securities, in each case in connection with a Fundamental Event, will not be
deemed a Transfer of beneficial ownership of the underlying shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Trust</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Voting Power Demand</U>&rdquo; has the
meaning set forth in <U>Section 5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Voting Power Exchange</U>&rdquo; has
the meaning set forth in <U>Section 5(c)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Voting Power Exchange Closing</U>&rdquo;
has the meaning set forth in <U>Section 5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Voting Securities</U>&rdquo; shall (i)
with respect to the Company, have the meaning set forth in the Company Charter, together with any shares of a new class or series of capital
stock of the Company issued after the date hereof which by the terms of any amendment to the Company Charter (including through the effectiveness
of a Preferred Stock Designation (as defined in the Company Charter)) is designated as a Voting Security and (ii) with respect to a Surviving
Company, mean stock of any class or series entitled to vote generally in the election of directors (or, with respect to any entity that
is not a corporation, any equity interest entitled to vote generally in the election of the governing body of such entity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Upon Dilutive Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>If the Company proposes to consummate any Dilutive Event with respect to a Group or receives notice of any occurrence, event or fact
that would reasonably be expected to cause, or has caused, a Dilutive Event with respect to a Group and, in each case, the number of Available
Series B Shares of such Group at the time of such Dilutive Event is a positive number, the Company shall provide prompt written notice
to Dr. Malone (a &ldquo;<U>Dilutive Event Notice</U>&rdquo;), specifying the number and series of the shares of Voting Securities involved
in such Dilutive Event, the nature and timing of the Dilutive Event, the Group with respect to which the Dilutive Event has occurred or
will occur, a reasonable estimate of the Malone Voting Power in such Group after giving effect to such Dilutive Event (for the avoidance
of doubt, without giving effect to any Dilutive Event Exchange in respect thereof) and a reasonable estimate of the number of shares of
Series C Common Stock of such Group to be exchanged by Dr. Malone and the Trust collectively in connection with such Dilutive Event.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(b)</TD><TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Subject to the last sentence of <U>Section 2(c)</U>,
the consummation and closing of any Dilutive Event Exchange will take place as promptly as practicable following the latest to occur of
(x) the receipt of a Dilutive Event Notice by Dr. Malone, (y) the occurrence of the Dilutive Event, and (z) the receipt of any necessary
regulatory approvals required for Dr. Malone and the Company to complete such Dilutive Event Exchange (including pursuant to the HSR Act
or any other Competition Law) (the &ldquo;<U>Dilutive Event Exchange Closing</U>&rdquo;), and at a location and time agreed to by Dr.
Malone and the Company; <I>provided, however</I>, that the conditions set forth in <U>Sections 10, 11</U> and <U>12</U> shall have been
satisfied (or waived by the party entitled to the benefit thereof).</P></TD></TR>
                                                                                                                                              </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The number of shares of Series C Common Stock of a Group which shall be exchanged by Dr. Malone and/or the Trust in the Dilutive Event
Exchange shall be an amount equal to the lesser of (x) the number of shares of Series B Common Stock of the same Group, the beneficial
ownership of which by Dr. Malone or the Trust would cause the Malone Voting Power of such Group immediately following the consummation
and closing of such Dilutive Event Exchange to be as close as possible to being equal to, but without being greater than, the Target Voting
Power, and (y) the number of Available Series B Shares of such Group at such time. The Company shall determine such number of shares to
be exchanged and provide Dr. Malone with notice of the same at least five Business Days prior to the Dilutive Event Exchange Closing (which
notice may be included in a Dilutive Event Notice); <I>provided, however</I>, that Dr. Malone may elect to exchange fewer (or no) shares
of such Series C Common Stock upon written notice to the Company.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(d)</TD><TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">At any Dilutive Event Exchange Closing, on the terms
and subject to the conditions contained in this Agreement (including after giving effect to any adjustments in accordance with <U>Section
19(d)</U> hereof):</P></TD></TR>
                                                                           </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>Dr. Malone and the Trust, as applicable, shall convey, transfer and deliver to the Company their respective number of shares of Series
C Common Stock of the applicable Group determined in accordance with <U>Section 2(c),</U> free and clear of all Encumbrances other than
Permitted Encumbrances;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>the Company shall issue and/or deliver to Dr. Malone and the Trust, as applicable, such number of shares of Series B Common Stock
of the same Group as is equal to such number of shares of Series C Common Stock of such Group delivered by Dr. Malone and the Trust, respectively,
and such shares of Series B Common Stock shall be duly authorized, validly issued, fully paid and nonassessable and free and clear of
all Encumbrances other than Permitted Encumbrances; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>the Company and Dr. Malone and the Trust, as applicable, will duly execute and deliver a cross receipt each acknowledging the receipt
of the shares of Common Stock delivered to it in connection therewith (the transactions described in this clause (d) being a &ldquo;<U>Dilutive
Event Exchange</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reverse Exchange Upon Accretive Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.5in; text-align: left">(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">If the Company proposes to consummate any Accretive Event with respect to a Group or receives notice of any occurrence, event or fact that would reasonably be expected to cause, or has caused, an Accretive Event with respect to a Group, the Company shall provide prompt written notice to Dr. Malone (an &ldquo;Accretive Event Notice&rdquo;), specifying the number and series of the shares of Voting Securities involved in such Accretive Event, the nature and timing of the Accretive Event, the Group with respect to which the Accretive Event has occurred or will occur, a reasonable estimate of the Malone Voting Power in such Group after giving effect to such Accretive Event (for the avoidance of doubt, without giving effect to any Reverse Exchange in respect thereof) and a reasonable estimate of the number of Reverse Exchange Shares of such Group to be exchanged by Dr. Malone and the Trust collectively in connection with such Accretive Event.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in"></TD>
    <TD STYLE="vertical-align: top; width: 0.5in; text-align: left">(b)</TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif">Within five (5) Business Days after receipt of an Accretive Event Notice by Dr. Malone or on the closing date provided in such Accretive Event Notice and, to the extent practicable, prior to or concurrently with the consummation of the Accretive Event (or, in the case of subsection (ii) of the definition of Accretive Event, prior to the occurrence of the Accretive Event), Dr. Malone or the Trust and the Company shall consummate a Reverse Exchange (the &ldquo;Reverse Exchange Closing&rdquo;) at a location and time agreed to by Dr. Malone and the Company; provided, however, that the conditions set forth in Sections 10, 11 and 12 shall have been satisfied (or waived by the party entitled to the benefit thereof).</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">At a Reverse Exchange Closing, on the terms and subject to the conditions contained in this Agreement (including after giving effect to any adjustments in accordance with Section 19(d) hereof):</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>Dr. Malone or the Trust shall convey, transfer and deliver to the Company shares of Series B Common Stock of the Group which was the
subject of the Accretive Event in the amount necessary to cause the Malone Voting Power in such Group to be as close as possible to being
equal to, but without being greater than, the Target Voting Power after giving effect to such Accretive Event and Reverse Exchange Closing
(such shares of the applicable Group, the &ldquo;<U>Reverse Exchange Shares</U>&rdquo;), free and clear of all Encumbrances other than
Permitted Encumbrances;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>the Company shall issue and/or deliver to Dr. Malone and the Trust, as applicable, such number of shares of Series C Common Stock
of the same Group as is equal to such number of Reverse Exchange Shares of such Group delivered by Dr. Malone and the Trust, respectively,
and such shares shall be duly authorized, validly issued, fully paid and nonassessable and free and clear of all Encumbrances other than
Permitted Encumbrances; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>the Company and Dr. Malone and the Trust, as applicable, will duly execute and deliver a cross receipt each acknowledging the receipt
of the shares of Common Stock delivered to it in connection therewith (the transactions described in this clause (c) being a &ldquo;<U>Reverse
Exchange</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Upon Fundamental Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>Subject to <U>Sections 4(b)</U> and <U>(c)</U>, in the event that the Company proposes to consummate a Fundamental Event in respect
of one or more Groups, then, the Company shall elect (with such election to be at the Company&rsquo;s sole discretion as approved by a
Special Committee or a majority of the Independent Directors), with respect to each such affected Group, that either</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>the Company shall provide for Dr. Malone or the Trust to receive the same per share amount and form of consideration for each Malone
Series C Exchangeable Share of such Group then outstanding and beneficially owned by Dr. Malone or the Trust as the per share amount and
form of consideration to be received by holders of Series B Common Stock of such Group in such Fundamental Event, and Dr. Malone or the
Trust, as applicable, will waive (or cause to be waived) the right to receive the consideration that otherwise would be received with
respect to such Malone Series C Exchangeable Shares of such Group; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>immediately prior to the consummation of such Fundamental Event, the Company and Dr. Malone shall consummate, and the Company and
the Trust shall separately consummate, an exchange whereby (x) the Company shall issue and/or deliver to Dr. Malone and/or the Trust,
as applicable, one share of Series B Common Stock of the applicable Group for each Malone Series C Exchangeable Share of the same Group
then outstanding and beneficially owned by Dr. Malone or the Trust, respectively, and (y) Dr. Malone and/or the Trust, as applicable,
shall deliver to the Company their respective Malone Series C Exchangeable Shares of such Group, which shall result in Dr. Malone and
the Trust holding shares of Series B Common Stock of such Group (in lieu of such Malone Series C Exchangeable Shares of such Group) that
are entitled to receive the same per share amount and form of consideration to be received by Dr. Malone and the Trust, respectively,
for his or its other shares of Series B Common Stock of such Group (a &ldquo;<U>Fundamental Event Exchange</U>&rdquo; and the consummation
of a Fundamental Event Exchange, a &ldquo;<U>Fundamental Event Exchange Closing</U>&rdquo;); <I>provided, however</I>, that the conditions
set forth in <U>Sections 10</U>, <U>11</U> and <U>12</U> shall have been satisfied (or waived by the party entitled to the benefit thereof).
At a Fundamental Event Exchange Closing, if applicable, the Company and Dr. Malone and the Trust, as applicable, will duly execute and
deliver a cross receipt each acknowledging the receipt of the shares of Common Stock delivered to it in connection therewith.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>If pursuant to the Fundamental Event in respect of a particular Group, the type, form and amount of consideration to be received by
holders of Series B Common Stock and Series C Common Stock of such Group is identical, then <U>Section 4(a)</U> shall be inapplicable
with respect to the Fundamental Event at such Group.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Notwithstanding the discretion afforded to the Company in Section 4.1(a), if its election of Section 4(a)(i) over Section 4(a)(ii)
(or vice versa) would (x) have a materially more adverse effect from a taxation or regulatory perspective on Dr. Malone or the Trust than
the option not so elected and (y) have no material economic, taxation or regulatory benefit to the Company greater than the option not
so elected, the Company shall not be entitled to make such election without the prior written consent of Dr. Malone.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting Power Exchange</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>If on (x) the last day of any calendar quarter or (y) a date that is at least five but no more than ten Business Days prior to the
record date for any matter submitted to the stockholders of the Company for a vote, the Malone Voting Power in the Company would be less
than the Target Voting Power if some or all Available Series B Shares of one or more Groups were delivered to Dr. Malone or the Trust
as of such date (the number of Available Series B Shares that may be delivered without resulting in the Malone Voting Power in the Company
exceeding the Target Voting Power, the &ldquo;<U>Maximum Amount</U>&rdquo;), Dr. Malone and the Trust may demand (a &ldquo;<U>Voting Power
Demand</U>&rdquo;) that the Company exchange the Maximum Amount of Available Series B Shares of any or all Groups on a one for one basis
for shares of Series C Common Stock of such Group or Groups notwithstanding that immediately following such exchange the Malone Voting
Power would exceed the Target Voting Power for any one or more Groups; <I>provided,</I> that (a) following any such exchange, the Malone
Voting Power in the Company must be less than or equal to the Target Voting Power and (b) with respect to any Group where the Malone Voting
Power would exceed the Target Voting Power immediately following such exchange, Dr. Malone and the Trust hereby agree that on any matter
submitted by the Company to the stockholders of that Group, voting together as a separate class, for approval, Dr. Malone and the Trust
will vote, or cause to be voted, the Voting Securities of such Group beneficially owned by them that represent voting power in excess
of the Target Voting Power of such Group in the same manner and in the same proportion as voted by the holders of Voting Securities of
that Group other than Dr. Malone and any holder of Voting Securities beneficially owned by Dr. Malone, and his or their Controlled Affiliates
(the &ldquo;<U>Other Voting Securities</U>&rdquo;), such that, for any such matter, the Voting Securities beneficially owned by Dr. Malone
in excess of the Target Voting Power of such Group shall reflect voting results with respect to &ldquo;shares voted for&rdquo;, &ldquo;shares
voted against&rdquo;, &ldquo;shares abstained&rdquo;, &ldquo;broker non-votes&rdquo; and &ldquo;shares not present at the meeting&rdquo;
proportionate to such aggregate voting results for the Other Voting Securities.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(b)</TD><TD>No later than four (4) Business Days after the receipt
by the Company of written notice by Dr. Malone or the Trust of a Voting Power Demand (which notice shall specify the number of Voting
Securities beneficially owned by Dr. Malone with respect to each Group and with respect to the Company), Dr. Malone or the Trust and the
Company shall consummate a Voting Power Exchange (the &ldquo;<U>Voting Power Exchange Closing</U>&rdquo;) at a location and time agreed
to by Dr. Malone and the Company; <I>provided, however</I>, that the conditions set forth in <U>Sections 10</U>, <U>11</U> and <U>12</U>
shall have been satisfied (or waived by the party entitled to the benefit thereof).</TD></TR>
                                                                                         </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<!-- Field: Split-Segment; Name: 01 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%"></TD>
  <TD STYLE="width: 3%">(c)</TD>
  <TD STYLE="width: 93%">At any Voting Power Exchange Closing, on the terms and subject to the conditions contained in this Agreement (including after giving
effect to any adjustments in accordance with <U>Section 19(d)</U> hereof):</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 5%">(i)</TD><TD STYLE="width: 88%">Dr. Malone and the Trust, as applicable, shall convey, transfer and deliver to the Company a number of shares of Series C Common Stock
of one or more Groups in an amount up to the Maximum Amount of Available Series B Shares of such Group or Groups, free and clear of all
Encumbrances other than Permitted Encumbrances;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 5%">(ii)</TD><TD STYLE="width: 88%">the Company shall issue and/or deliver to Dr. Malone and the Trust, as applicable, such number of shares of Series B Common Stock
of the same Group or Groups as is equal to such number of shares of Series C Common Stock of such Group or Groups delivered by Dr. Malone
and the Trust, respectively, and such shares of Series B Common Stock shall be duly authorized, validly issued, fully paid and nonassessable
and free and clear of all Encumbrances other than Permitted Encumbrances; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 5%">(iii)</TD><TD STYLE="width: 88%">the Company and Dr. Malone and the Trust, as applicable, will duly execute and deliver a cross receipt each acknowledging the receipt
of the shares of Common Stock delivered to it in connection therewith (the transactions described in this clause (c) being a &ldquo;<U>Voting
Power Exchange</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%">6.</TD><TD STYLE="width: 96%"><U>Rescission.</U> If the applicable Exchange Event is not consummated either prior
                             to or within ten (10) Business Days following an Exchange Closing, or following a Voting Power Exchange
                             Closing in connection with a stockholder meeting, the applicable meeting of stockholders is cancelled,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(a)</TD><TD STYLE="width: 93%">the applicable Exchange will be automatically rescinded and treated as if neither the Exchange nor the Exchange Closing had ever occurred
(the &ldquo;<U>Rescission</U>&rdquo;);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(b)</TD><TD STYLE="width: 93%">each of the Company, Dr. Malone and the Trust hereby waives, and none of the Company, Dr. Malone or the Trust shall have, any rights,
duties or obligations of any kind (other than rights, duties or obligations to effect the Rescission) in respect of the Exchange to receive
or retain, (x) in the case of Dr. Malone and the Trust, (A) following any Dilutive Event Exchange Closing, any shares of Series B Common
Stock issued or delivered in connection therewith; (B) following any Reverse Exchange Closing, any shares of Series C Common Stock issued
or delivered in connection therewith; (C) following any Fundamental Event Exchange Closing, any shares of Series B Common Stock issued
or delivered in connection therewith; and (D) following a Voting Power Exchange Closing, any shares of Series B Common Stock issued or
delivered in connection therewith (such shares referred to in clauses (A), (B), (C) and (D), collectively the &ldquo;<U>Malone Rescission
Shares</U>&rdquo;), and, (y) in the case of the Company, (A) following any Dilutive Event Exchange Closing, any shares of Series C Common
Stock delivered in connection therewith; (B) following any Reverse Exchange Closing, any Reverse Exchange Shares delivered in connection
therewith; (C) following any Fundamental Event Exchange Closing, any shares of Series C Common Stock delivered in connection therewith;
and (D) following a Voting Power Exchange Closing, any shares of Series C Common Stock delivered in connection therewith (such shares
referred to in clauses (A), (B), (C) and (D), collectively the &ldquo;<U>Company Rescission Shares</U>&rdquo;); and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(c)</TD><TD STYLE="width: 93%">each of the Company, on the one hand, and Dr. Malone and the Trust, on the other hand, will take such actions as are reasonably necessary
to effect such Rescission, and each will be deemed, upon the effectiveness of such Rescission, to make appropriate representations and
warranties to the other with respect to the valid issuance and conveyance, as applicable, and the lack of any Encumbrances upon the Malone
Rescission Shares or the Company Rescission Shares (other than Permitted Encumbrances), as applicable, so as to vest in the other good
and valid title to the Malone Rescission Shares or the Company Rescission Shares, as applicable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">7.</TD>
  <TD STYLE="width: 96%"><U>Representations</U>.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%"></TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%"><U>Representations of Dr. Malone</U>. Dr. Malone, on behalf of himself individually and as trustee of the Trust, represents and warrants
to the Company that:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(i)</TD>
  <TD STYLE="width: 88%">as of the date of this Agreement, Dr. Malone beneficially owns the number of shares of each series and Group of Common Stock set forth
on <U>Exhibit A</U> hereto;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(ii)</TD>
  <TD STYLE="width: 88%">(w) as of any Dilutive Event Exchange Closing, Dr. Malone will beneficially own or own of record such number of shares of Series C Common
Stock of the applicable Group to be delivered and exchanged by Dr. Malone or the Trust at the Dilutive Event Exchange Closing, free and
clear of all Encumbrances other than Permitted Encumbrances, (x) as of any Reverse Exchange Closing, Dr. Malone will beneficially own
or own of record such number of Reverse Exchange Shares of the applicable Group to be delivered and exchanged by Dr. Malone or the Trust
at the Reverse Exchange Closing, free and clear of all Encumbrances other than Permitted Encumbrances, (y) as of any Fundamental Event
Exchange Closing, Dr. Malone will beneficially own or own of record such number of Malone Series C Exchangeable Shares of the applicable
Group to be delivered and exchanged by Dr. Malone or the Trust at the Fundamental Event Exchange Closing, free and clear of all Encumbrances
other than Permitted Encumbrances, and (z) as of any Voting Power Exchange Closing, Dr. Malone will beneficially own or own of record
such number of shares of Series C Common Stock of the applicable Group or Groups to be delivered and exchanged by Dr. Malone or the Trust
at the Voting Power Exchange Closing, free and clear of all Encumbrances other than Permitted Encumbrances;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(iii)</TD>
  <TD STYLE="width: 88%">upon delivery to the Company of the shares of Series C Common Stock, Reverse Exchange Shares or Malone Series C Exchangeable Shares at
the applicable Exchange Closing, in the manner provided in this Agreement, the Company will have good and valid title to such shares
of Series C Common Stock, Reverse Exchange Shares or Malone Series C Exchangeable Shares, free and clear of all Encumbrances other than
Permitted Encumbrances and Encumbrances created by the Company or any of its Controlled Affiliates;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(iv)</TD>
  <TD STYLE="width: 88%">the Trust is a trust duly organized and validly existing under the Laws of the State of Florida and each of Dr. Malone and the Trust
have all requisite legal capacity to execute and deliver this Agreement and to perform their obligations under this Agreement, including
any Exchange and the other transactions contemplated hereby;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(v)</TD>
  <TD STYLE="width: 88%">this Agreement has been duly and validly executed and delivered by Dr. Malone and the Trust and, assuming the due execution and delivery
hereof by the Company, is a valid and binding agreement of Dr. Malone and the Trust, enforceable in accordance with its terms, except
as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors&rsquo;
rights generally, or by principles governing the availability of equitable remedies;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(vi)</TD>
  <TD STYLE="width: 88%">the execution, delivery and performance by Dr. Malone and the Trust of this Agreement and the consummation by Dr. Malone or the Trust
of any Exchange and the other transactions contemplated hereby requires no action by or in respect of, or filings with, any Governmental
Authority other than (x) as may be required by Competition Laws, including the HSR Act, (y) such clearances, consents, approvals, Orders,
licenses, authorizations, registrations, declarations, permits, filings and notifications as may be required under applicable securities
Laws and (z) any actions or filings under Laws (other than Competition Laws) the absence of which would not reasonably be expected, individually
or in the aggregate, to have a material adverse effect on the ability of Dr. Malone or the Trust to consummate any Exchange or the other
transactions contemplated hereby, or prevent or materially delay the consummation of any Exchange or the other transactions contemplated
by this Agreement;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(vii)</TD>
  <TD STYLE="width: 88%">the execution and delivery of this Agreement, and the performance by Dr.&nbsp;Malone and the Trust of this Agreement and the consummation
by Dr.&nbsp;Malone or the Trust of any Exchange and the other transactions contemplated hereby will not (x) violate any applicable Law,
(y) conflict with or constitute a default, breach or violation of (with or without notice or lapse of time, or both) the terms, conditions
or provisions of, or result in the acceleration of (or the creation in any Person of any right to cause the acceleration of) any performance
of any obligation or any increase in any payment required by, or the termination, suspension, modification, impairment or forfeiture
(or the creation in any Person of any right to cause the termination, suspension, modification, impairment or forfeiture) of any contract,
agreement or instrument to which Dr. Malone or the Trust is subject, which would prevent Dr. Malone or the Trust from performing any
of their obligations hereunder, or (z) require any consent by or approval of or notice to any other Person or entity (other than a Governmental
Authority), except, in the case of clauses (x), (y) and (z), as would not have a material adverse effect, individually or in the aggregate,
on Dr. Malone&rsquo;s or the Trust&rsquo;s ability to consummate any Exchange or the other transactions contemplated hereby, or prevent
or materially delay the consummation of any Exchange or the other transactions contemplated by this Agreement; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(viii)</TD>
  <TD STYLE="width: 88%">each of Dr. Malone and the Trust is a sophisticated investor and an accredited investor (as defined in Rule 501(a) of Regulation D of
the Securities Act), with sufficient knowledge and experience in financial and business matters to evaluate the merits and risks of any
Exchange, and the other transactions contemplated hereby, and each of Dr. Malone and the Trust acknowledges that the offer and sale of
any Company Exchange Shares hereunder has not been registered under the Securities Act or any securities Laws of any state and that such
Company Exchange Shares may not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of without registration
under the Securities Act, except pursuant to an exemption from such registration available under the Securities Act.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%"><U>Representations of the Company</U>. The Company represents and warrants to Dr. Malone and the Trust that:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(i)</TD>
  <TD STYLE="width: 88%">upon issuance and/or delivery to Dr. Malone or the Trust of the Company Exchange Shares at an Exchange Closing in the manner provided
in this Agreement, such Company Exchange Shares will be duly authorized, validly issued, fully paid and nonassessable and Dr. Malone
or the Trust, as applicable, will have good and valid title to such Company Exchange Shares so delivered, free and clear of all Encumbrances
other than Permitted Encumbrances and Encumbrances created by Dr. Malone or any of his Affiliates;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(ii)</TD>
  <TD STYLE="width: 88%">the Company is a Delaware corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware,
and has full power and authority to execute and deliver this Agreement and to consummate any Exchange and the other transactions contemplated
hereby;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(iii)</TD>
  <TD STYLE="width: 88%">the execution and delivery of this Agreement by the Company, and performance of this Agreement by the Company, including the consummation
of any Exchange and the other transactions contemplated hereby, has been duly authorized by all requisite corporate power;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(iv)</TD>
  <TD STYLE="width: 88%">this Agreement has been duly and validly executed and delivered by the Company and, assuming the due execution and delivery hereof by
Dr. Malone and the Trust, is a valid and binding agreement of the Company, enforceable in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting creditors&rsquo; rights generally,
or by principles governing the availability of equitable remedies;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(v)</TD>
  <TD STYLE="width: 88%">the execution, delivery and performance by the Company of this Agreement and the consummation by the Company of any Exchange, and the
other transactions contemplated hereby requires no action by or in respect of, or filings with, any Governmental Authority, other than
(x) as may be required by any Competition Laws, including the HSR Act, (y) such clearances, consents, approvals, Orders, licenses, authorizations,
registrations, declarations, permits, filings and notifications as may be required under applicable securities Laws and (z) any actions
or filings under Laws (other than Competition Laws) the absence of which would not reasonably be expected, individually or in the aggregate,
to have a material adverse effect on the ability of the Company to consummate any Exchange or the other transactions contemplated hereby
or prevent or materially delay the consummation of any Exchange or the other transactions contemplated by this Agreement; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 7%">&nbsp;</TD>
  <TD STYLE="width: 5%">(vi)</TD>
  <TD STYLE="width: 88%">the execution, delivery and performance by the Company of this Agreement and the consummation of any Exchange and the other transactions
contemplated hereby will not (x) violate any applicable Law, (y) conflict with or constitute a default, breach or violation of (with
or without notice or lapse of time, or both) the terms, conditions or provisions of, or result in the acceleration of (or the creation
in any Person of any right to cause the acceleration of) any performance of any obligation or any increase in any payment required by,
or the termination, suspension, modification, impairment or forfeiture (or the creation in any Person of any right to cause the termination,
suspension, modification, impairment or forfeiture) of any contract, agreement or instrument to which the Company is subject, including
without limitation the Company Charter, the Company Bylaws or similar organization documents of any of the Company&rsquo;s Controlled
Affiliates, which would prevent it from performing any of its obligations hereunder, or (z) require any consent by or approval of or
notice to any other Person or entity (other than a Governmental Authority), except, in the case of clauses (x), (y) and (z), as would
not have a material adverse effect, individually or in the aggregate, on the Company&rsquo;s ability to consummate any Exchange and the
other transactions contemplated hereby, or prevent or materially delay the consummation of any Exchange and the other transactions contemplated
by this Agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">8.</TD>
  <TD STYLE="width: 96%"><U>Reasonable Best Efforts and Other Covenants</U>.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%">The Company, Dr. Malone and the Trust shall cooperate with each other and use their reasonable best efforts to (i) consummate any Exchange
and any other transactions contemplated by this Agreement in the manner contemplated by this Agreement and (ii) execute documents reasonably
necessary to effect any Exchange and any other transactions contemplated by this Agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%">The Company, Dr. Malone and the Trust shall cooperate with each other and shall prepare and file all necessary filings, applications,
notices and/or similar instruments or documentation, and use their respective reasonable best efforts to obtain as promptly as practicable
all consents, approvals or non-objections, as applicable, of all third parties and Governmental Authorities that, in each case, are required
under applicable Law to consummate any Exchange and the other transactions contemplated by this Agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(c)</TD>
  <TD STYLE="width: 93%">Dr. Malone (directly or through his executors, administrators, or testamentary trustees) may Transfer the right to receive Available
Series B Shares of any one or more Groups to, and only to (i) prior to Dr. Malone&rsquo;s death or incapacity, a Proposed Transferee
who prior to such Transfer executes a Successor Exchange Agreement covering all shares of Series B Common Stock of such Group then beneficially
owned by Dr. Malone and all Available Series B Shares of such Group or (ii) a Proposed Transferee who, within three months of Dr. Malone&rsquo;s
death or incapacity, executes a Successor Exchange Agreement covering all shares of Series B Common Stock of such Group beneficially
owned by Dr. Malone immediately prior to his death or incapacity and all Available Series B Shares of such Group; <I>provided</I>, that
any Available Series B Shares hereunder may be released or exchanged to such a Proposed Transferee only following the execution of a
Successor Exchange Agreement on the terms and subject to the conditions of such Successor Exchange Agreement. For the avoidance of doubt,
neither Dr. Malone nor the Trust shall Transfer the right to obtain any Available Series B Shares (including through a series of one
or more Transfers of Series B Common Stock (including Available Series B Shares issued and/or delivered in a Dilutive Event Exchange)
to the same Person or Persons) except to a Proposed Transferee pursuant to a Successor Exchange Agreement, and Available Series B Shares
hereunder may be released or exchanged only on the terms and subject to the conditions of this Agreement or a Successor Exchange Agreement.
The Company shall negotiate in good faith a Successor Exchange Agreement with each Proposed Transferee to whom Dr. Malone (directly or
through his executors, administrators or testamentary trustees) seeks to Transfer Available Series B Shares pursuant to this Section
8(c).</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(d)</TD>
  <TD STYLE="width: 93%">Dr. Malone shall promptly provide notice to the Company of any Transfer or acquisition by Dr. Malone or the Trust of any Voting Securities.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(e)</TD>
  <TD STYLE="width: 93%">Unless otherwise determined by a Special Committee or a majority of the Independent Directors, in connection with any Fundamental Event
involving (i) a split-off or spin-off or (ii) a combination, consolidation or merger as a result of which the stockholders of the Company
are entitled to receive all or substantially all of the Voting Securities of the Surviving Company and, in each case, Dr. Malone would
(A) serve as an officer or director of the Surviving Company entitling him to the exemptions provided by Rule 16b-3 promulgated under
the Exchange Act if an Exchange were approved by the board of directors of the Surviving Company or a committee of such board of directors
composed solely of two or more Non-Employee Directors (as defined in such Rule) and (B) beneficially own 40% or more of the outstanding
voting power of the Surviving Company, Dr. Malone, the Trust and the Company (acting through a Special Committee or the Independent Directors)
shall, and shall cause the Surviving Company to, negotiate an exchange agreement with respect to the Surviving Company in substantially
the form of this Agreement <FONT STYLE="background-color: white">in order to replicate the benefits and obligations of Dr. Malone, the
Trust and the Company as exist under this Agreement as of the effective time of such Fundamental Event.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(f)</TD>
  <TD STYLE="width: 93%">In the event Dr. Malone no longer serves as an officer or director of the Company such that Rule 16b-3 promulgated under the Exchange
Act would not be available to exempt the Exchange transactions hereunder, then neither Dr. Malone nor the Trust shall be required to
participate in any Exchange (including, without limitation any Reverse Exchange) that would result in liability under Section 16(b) of
the Exchange Act.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">9.</TD>
  <TD STYLE="width: 96%"><U>Tax Matters</U>. Each of the Company, the Trust and Dr. Malone acknowledges and agrees that each Exchange is a transaction intended
to qualify, for U.S. federal income tax purposes, as an exchange pursuant to Section 1036(a) of the Code and/or a reorganization under
Section 368(a)(1)(E) of the Code, in either case, which is tax-free except to the extent of any consideration received by the Trust or
Dr. Malone other than Company Exchange Shares, and except to the extent otherwise required pursuant to a &ldquo;determination&rdquo;
(within the meaning of Section 1313(a) of the Code) or a change in applicable Tax Law occurring after the date of this Agreement, the
Company, the Trust and Dr. Malone agree not to take any position on any Tax Return, or take any position for Tax purposes, that is inconsistent
with any Exchange qualifying for U.S. federal income tax purposes as an exchange under Section 1036(a) of the Code and/or a reorganization
under Section 368(a)(1)(E) of the Code which is tax-free except to the extent of any consideration received by the Trust or Dr. Malone
other than Company Exchange Shares; provided, that in the event of a Rescission, the Company, the Trust and Dr. Malone shall not take
any position on any Tax Return, or take any position for Tax purposes, that is inconsistent with an Exchange and any exchange effecting
a Rescission (a &ldquo;<U>Rescission Exchange</U>&rdquo;) qualifying, for U.S. federal income tax purposes, either (A) to the extent
the Exchange and a corresponding Rescission Exchange occur in the same tax year, as disregarded transactions or exchanges under Section
1036(a) of the Code which are disregarded or tax-free, as applicable, except to the extent of any consideration received by the Trust
or Dr. Malone other than Company Exchange Shares and Company Rescission Shares, or (B) to the extent the Exchange and the corresponding
Rescission Exchange occur in different tax years, as exchanges under Section 1036(a) of the Code which are tax-free except to the extent
of any consideration received by the Trust or Dr. Malone other than Company Exchange Shares and Company Rescission Shares. For the avoidance
of doubt, consideration received by the Trust or Dr. Malone includes, as applicable, any costs or expenses paid on behalf of or reimbursed
to the Trust or Dr. Malone. This Agreement shall constitute a &ldquo;plan of reorganization&rdquo; within the meaning of Sections 1.368-2(g)
and 1.368-3(a) of the U.S. Treasury Regulations promulgated under the Code with respect to each Exchange under this Agreement. At each
Exchange Closing, Dr. Malone and the Trust shall each provide to the Company a valid executed Internal Revenue Service Form W-9 (or applicable
successor form) reasonably satisfactory to the Company with respect to Dr. Malone and the Trust, respectively.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">10.</TD>
  <TD STYLE="width: 96%"><U>Conditions to Parties&rsquo; Obligation to Effect an Exchange</U>. The respective obligations of the Company, Dr. Malone and the Trust
to effect any Exchange shall be subject to the satisfaction, by each of Dr. Malone, the Trust and the Company prior to or at the relevant
Exchange Closing of the following conditions:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%"><U>No Injunctions or Restraints</U>. No Order entered, enacted, promulgated, enforced or issued by any court or other Governmental Authority
of competent jurisdiction, shall be in effect which prohibits, renders illegal or enjoins the consummation of such Exchange; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%"><U>Occurrence of Event.</U></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.65in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Dilutive Event</U>. In the case of a Dilutive Event Exchange, the relevant Dilutive Event shall have occurred.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.65in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Accretive Event</U>. In the case of a Reverse Exchange, the relevant Accretive Event shall have already occurred or be reasonably
expected to occur concurrently with or promptly following the Reverse Exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.65in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD><U>Fundamental Event</U>. In the case of a Fundamental Event Exchange, the relevant Fundamental Event shall be reasonably expected
to occur immediately following the Fundamental Event Exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">11.</TD>
  <TD STYLE="text-align: left; width: 96%"><U>Conditions to the Company&rsquo;s Obligation to Effect an Exchange</U>. The obligation of the Company to effect any Exchange is also
subject to the satisfaction, or (to the extent legally permissible) waiver in writing by the Company, prior to or at the relevant Exchange
Closing of the following conditions:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%"><U>Representations and Warranties</U>. The representations and warranties of Dr. Malone and the Trust set forth in <U>Section 7(a)</U>
shall be true and correct in all material respects in each case as of the date of this Agreement and as of the Exchange Closing as though
made on and as of the Exchange Closing, except for (x) those representations and warranties made as of a specified date, which shall
be true and correct in all material respects as of such date, and (y) <I>de minimis </I>inaccuracies;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%"><U>Covenants</U>. Dr. Malone and the Trust shall have performed in all material respects all covenants required to be performed by them
prior to or at such Exchange Closing; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(c)</TD>
  <TD STYLE="width: 93%"><U>Closing Certificate</U>. Dr. Malone and the Trust shall have delivered to the Company a certificate duly signed by Dr. Malone, individually
and as trustee of the Trust, that the conditions set forth in <U>Sections 11(a)</U> and <U>(b)</U> have been satisfied.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">12.</TD>
  <TD STYLE="width: 96%"><U>Conditions to Dr. Malone&rsquo;s and the Trust&rsquo;s Obligation to Effect an Exchange</U>. The obligation of Dr. Malone and the
Trust to effect any Exchange is also subject to the satisfaction, or (to the extent legally permissible) waiver in writing by Dr. Malone
(individually and as trustee of the Trust), prior to or at the relevant Exchange Closing of the following conditions:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%"><U>Representations and Warranties</U>. The representations and warranties of the Company set forth in <U>Section 7(b)</U> shall be true
and correct in all material respects in each case as of the date of this Agreement and as of the Exchange Closing as though made on and
as of the Exchange Closing, except for (x) those representations and warranties made as of a specified date, which shall be true and
correct in all material respects as of such date, and (y) <I>de minimis </I>inaccuracies;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%"><U>Covenants</U>. The Company shall have performed in all material respects all other covenants required to be performed by it prior
to or at such Exchange Closing;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(c)</TD>
  <TD STYLE="width: 93%"><U>Section 16b-3</U>. The Board or a committee of the Board composed solely of two or more Non-Employee Directors (as defined in Rule
16b-3 promulgated under the Exchange Act) shall have adopted resolutions exempting the Exchange under Rule 16b-3 promulgated under the
Exchange Act; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(d)</TD>
  <TD STYLE="width: 93%"><U>Officer&rsquo;s Certificate</U>. The Company shall have delivered to Dr. Malone and the Trust a certificate duly signed by a duly
authorized officer of the Company that the conditions set forth in <U>Sections 12(a)</U>, <U>(b)</U> and <U>(c)</U> have been satisfied.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">13.</TD>
  <TD STYLE="width: 96%"><U>Termination</U>.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(a)</TD><TD STYLE="width: 93%">This Agreement will terminate and no longer apply with respect to the Common Stock of any particular Group beneficially owned by Dr.
Malone (i) upon the mutual consent of each of the parties hereto in a written instrument (in the case of the Company, upon the approval
of a Special Committee or a majority of Independent Directors), (ii) upon execution of a Successor Exchange Agreement covering all shares
of Series B Common Stock of such Group then beneficially owned by Dr. Malone and all Available Series B Shares of such Group or (iii)
other than in a circumstance where this Agreement is terminated pursuant to Section 13(a)(ii), upon the Malone Voting Power ceasing to
constitute at least 20% of the outstanding voting power of such Group.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(b)</TD><TD STYLE="width: 93%">This Agreement will terminate in its entirety and immediately cease to be of any further force and effect (i) pursuant to the mutual
consent of each of the parties hereto in a written instrument (in the case of the Company, upon the approval of a Special Committee or
a majority of Independent Directors), (ii) upon execution of a Successor Exchange Agreement covering all shares of Series B Common Stock
then beneficially owned by Dr. Malone and all Available Series B Shares of all Groups, or (iii) other than in a circumstance where this
Agreement is terminated pursuant to Section 13(b)(ii), upon the Malone Voting Power ceasing to constitute at least 20% of the outstanding
voting power of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(c)</TD><TD STYLE="width: 93%">If this Agreement is terminated in accordance with <U>Section 13(b)</U>, this Agreement shall forthwith become null and void and of
no effect and the rights and obligations of the parties hereto shall terminate, without liability of any party (or any stockholder, director,
officer, employee, consultant, financial advisor, legal counsel, financing source, accountant, insurer or other advisor, agent or representative
of such party); <I>provided</I>, that, (i) in the event of a termination as a result of the death of Dr. Malone, the Company&rsquo;s obligation
in the last sentence of Section 8(c) shall survive for three months following such termination and (ii) nothing contained herein shall
relieve any party to this Agreement from any liability for damages resulting from (x) fraud or (y) willful material breach by such party
prior to such termination, in each case, as determined by a court of competent jurisdiction pursuant to a final and nonappealable judgment.
For purposes of this Agreement, &ldquo;willful material breach&rdquo; means a material breach of a party&rsquo;s covenants and agreements
set forth in this Agreement that is the consequence of an act or omission by a party with the knowledge that the taking of such act or
failure to take such action would be a material breach of such party&rsquo;s covenants or agreements (<I>provided</I>, that, with respect
to the Company, knowledge includes the actual knowledge, after due inquiry, of the senior executive management team of the Company).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 3%">(d)</TD><TD STYLE="width: 93%">For the avoidance of doubt, (i) upon the termination of this Agreement with respect to any Group (other than a termination pursuant
to Section 13(a)(ii)), any and all Available Series B Shares of such Group, if any, will be immediately and automatically forfeited and
cancelled and no Person shall have any right to obtain any such Available Series B Shares of such Group and (ii) upon the termination
of this Agreement with respect to the Company (other than a termination pursuant to Section 13(b)(ii), any and all Available Series B
Shares, if any, will be immediately and automatically forfeited and cancelled and no Person shall have any right to obtain any Available
Series B Shares; <I>provided, however</I>, that upon the termination of this Agreement following the death of Dr. Malone, the executors,
administrators or testamentary trustees of Dr. Malone may Transfer the right to receive Available Series B Shares of any one or more Groups
pursuant to, and only pursuant to, Section 8(c) hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">14.</TD>
  <TD STYLE="width: 96%"><U>Applicable Law</U>. All disputes, claims or controversies arising out of or relating to this Agreement, or the negotiation, validity
or performance of this Agreement, or any Exchange and the other transactions contemplated hereby shall be governed by and construed in
accordance with the Laws of the State of Delaware without regard to its rules of conflict of Laws.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">15.</TD>
  <TD STYLE="width: 96%"><U>Jurisdiction</U>. Each of the parties hereto (a) irrevocably and unconditionally consents to submit itself to the sole and exclusive
personal jurisdiction of the Court of Chancery of the State of Delaware, or, solely if that court does not have subject matter jurisdiction,
the Superior Court of the State of Delaware, or, solely if the subject matter of the Action is one over which exclusive jurisdiction
is vested in the courts of the United States of America, a federal court sitting in the State of Delaware (collectively, the &ldquo;<U>Delaware
Courts</U>&rdquo;) in connection with any dispute, claim, or controversy arising out of or relating to this Agreement, any Exchange,
or the other transactions contemplated hereby, (b) waives any objection to the laying of venue of any such litigation in any of the Delaware
Courts, (c) agrees not to plead or claim in any such court that such litigation brought therein has been brought in an inconvenient forum
and agrees not otherwise to attempt to deny or defeat such personal jurisdiction or venue by motion or other request for leave from any
such court, and (d) agrees that it will not bring any Action in connection with any dispute, claim, or controversy arising out of or
relating to this Agreement or any Exchange and the other transactions contemplated hereby, in any court or other tribunal, other than
any of the Delaware Courts. All Actions arising out of or relating to this Agreement or any Exchange and the other transactions contemplated
hereby shall be heard and determined in the Delaware Courts. Each of the parties hereto hereby irrevocably and unconditionally agrees
that service of process in connection with any dispute, claim, or controversy arising out of or relating to this Agreement, any Exchange
and the other transactions contemplated hereby may be made upon such party by prepaid certified or registered mail, with a validated
proof of mailing receipt constituting evidence of valid service, directed to such party at the address specified in <U>Section 18</U>
hereof. Service made in such manner, to the fullest extent permitted by applicable Law, shall have the same legal force and effect as
if served upon such party personally within the State of Delaware. Nothing herein shall be deemed to limit or prohibit service of process
by any other manner as may be permitted by applicable Law.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">16.</TD>
  <TD STYLE="width: 96%"><U>Waiver of Jury Trial. </U> EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING
OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY EXCHANGE AND THE OTHER
TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT OF
THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS
AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <U>SECTION 16</U>.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">17.</TD>
  <TD STYLE="width: 96%"><U>Enforcement of this Agreement</U>. The parties acknowledge and agree that irreparable damage would occur and that the parties would
not have any adequate remedy at Law in the event that any of the provisions of this Agreement were not performed in accordance with their
specific terms or were otherwise breached and that monetary damages, even if available, would not be an adequate remedy therefor. It
is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement (without
the obligation to post a bond therefor) and to enforce specifically the terms and provisions of this Agreement in the Court of Chancery
of the State of Delaware, this being in addition to any other remedy to which they are entitled at Law or in equity.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">18.</TD>
  <TD STYLE="width: 96%"><U>Notices</U>. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be
deemed given (a) on the date of delivery if delivered personally or sent via e-mail or (b) on the first (1st) Business Day following
the date of dispatch if sent by a nationally recognized overnight courier (providing proof of delivery), in each case to the parties
at the following addresses (or at such other address for a party as shall be specified by like notice):</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">if to Dr. Malone or the Trust, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">John C. Malone<BR>
c/o Liberty Media Corporation<BR>
12300 Liberty Boulevard<BR>
Englewood, CO 80112<BR>
E-Mail: [Separately provided]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Sherman &amp; Howard L.L.C.<BR>
633 Seventeenth Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Suite 3000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Denver, CO 80202</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 10%">Attention:</TD>
  <TD STYLE="width: 86%">Steven D. Miller</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 86%">Jeffrey R. Kesselman</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 10%">E-Mail:</TD>
  <TD STYLE="width: 86%">[Separately provided]</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 86%">[Separately provided]</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">if to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Liberty Media Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">12300 Liberty Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Englewood, CO 80112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Attention: [Separately provided]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Email:&#9;[Separately provided]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Baker Botts L.L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">2001 Ross Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Suite 900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Dallas, Texas 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Attention: Samantha Crispin</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">Email: [Separately provided]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4%">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">19.</TD>
  <TD STYLE="width: 96%"><U>Miscellaneous</U>.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(a)</TD>
  <TD STYLE="width: 93%">Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be assigned, in whole or in part, by
operation of Law or otherwise by any of the parties hereto without the prior written consent of the other parties hereto (in the case
of the Company, acting upon the consent of a Special Committee or a majority of the Independent Directors). Any purported assignment
in breach of the foregoing is void <I>ab initio</I> and of no force and effect whatsoever. This Agreement is intended for the benefit
of the parties hereto and is not for the benefit of, nor may any provision hereof be enforced by, any other Person; <I>provided</I>,
<I>however</I>, that Dr. Malone&rsquo;s executors, administrators and testamentary trustees may, for three months following Dr. Malone&rsquo;s
death, enforce the last sentence of Section 8(c) hereof.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(b)</TD>
  <TD STYLE="width: 93%">This Agreement may be executed in separate counterparts, each of which will be an original and all of which taken together will constitute
one and the same agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(c)</TD>
  <TD STYLE="width: 93%">If, subsequent to the date hereof, further documents are reasonably requested in order to carry out the provisions and purposes of this
Agreement, the parties hereto will execute and deliver such further documents.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(d)</TD>
  <TD STYLE="width: 93%">When a reference is made in this Agreement to a Section, such reference shall be to a Section of this Agreement unless otherwise indicated.
The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement. Whenever the words &ldquo;include&rdquo;, &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement,
they shall be deemed to be followed by the words &ldquo;without limitation&rdquo;. The words &ldquo;hereof&rdquo;, &ldquo;herein&rdquo;
and &ldquo;hereunder&rdquo; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not
to any particular provision of this Agreement. Definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms. When this Agreement contemplates a certain number of securities, as of a particular date, such number of
securities (including Available Series B Shares) shall be deemed to be appropriately adjusted (without duplication) to account for stock
splits, stock dividends, recapitalizations, combinations of shares or other change affecting the outstanding shares of the Common Stock
or Voting Securities other than any Fundamental Event subject to Section 4. In the event the Company&rsquo;s stockholders approve an
amendment to the Company Charter to change the name of a tracking stock group, references to the prior name of such tracking stock group
and its securities in this Agreement shall be deemed to refer to the renamed tracking stock group and its securities.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(e)</TD>
  <TD STYLE="width: 93%">Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed (i) in the
case of an amendment, by each of parties hereto (in the case of the Company, upon the approval of a Special Committee or a majority of
the Independent Directors), and (ii) in the case of a waiver, by the party against whom the waiver is to be effective (in the case of
the Company, upon the approval of a Special Committee or a majority of the Independent Directors). No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof
preclude any other or further exercise thereof or the exercise of any other right, power or privilege.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(f)</TD>
  <TD STYLE="width: 93%">If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public policy,
all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect, insofar as the foregoing can
be accomplished without materially affecting the benefits anticipated by the parties to this Agreement. Upon such determination that
any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable
Law in an acceptable manner to the end that the Exchanges and the other transactions contemplated hereby are fulfilled to the greatest
extent possible.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(g)</TD>
  <TD STYLE="width: 93%">The parties acknowledge and confirm that each of their respective attorneys have participated jointly in the drafting, review and revision
of this Agreement and that it has not been written solely by counsel for one party and that each party has had the benefit of its independent
legal counsel&rsquo;s advice with respect to the terms and provisions hereof and its rights and obligations hereunder. Each party hereto,
therefore, stipulates and agrees that the rule of construction to the effect that any ambiguities are to be or may be resolved against
the drafting party shall not be employed in the interpretation of this Agreement to favor any party against another and that no party
shall have the benefit of any legal presumption or the detriment of any burden of proof by reason of any ambiguity or uncertain meaning
contained in this Agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 3%">(h)</TD>
  <TD STYLE="width: 93%">All costs and expenses incurred or to be incurred with this Agreement and the transactions contemplated hereby will be paid by the party
incurring such cost or expense, <I>provided</I>, that the Company shall pay (or reimburse Dr. Malone and the Trust) all reasonable out-of-pocket
costs and expenses incurred by Dr. Malone and the Trust, including the reasonable fees, charges and disbursements of counsel for Dr.
Malone and the Trust and any filing fees due for any filings pursuant to any Competition Law, including the HSR Act, in each case, necessary
or in connection with the preparation, negotiation, execution and consummation of this Agreement and any of the transactions contemplated
by this Agreement.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">JOHN C. MALONE</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ John C. Malone</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">JOHN C. MALONE 1995 REVOCABLE TRUST U/A DTD 3/6/1995</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 2%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0in; width: 48%">&nbsp;&nbsp;&nbsp;/s/ John C. Malone</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>&nbsp;&nbsp;&nbsp;John C. Malone</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;&nbsp;&nbsp;Trustee</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">LIBERTY MEDIA CORPORATION</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 2%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 48%">&nbsp;&nbsp;&nbsp;/s/ Renee L. Wilm</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>&nbsp;&nbsp;&nbsp;Renee L. Wilm</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;&nbsp;&nbsp;Chief Legal Officer</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lmca-20210728.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWEGbOdzZR+mYkxtmB3bam6ryIoMP1E0yigpsN2UdoP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:lmca="http://libertymedia.com/20210728" elementFormDefault="qualified" targetNamespace="http://libertymedia.com/20210728">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://libertymedia.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="lmca-20210728_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lmca-20210728_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lmca-20210728_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="lmca_LibertySiriusXmGroupCommonClassMember" name="LibertySiriusXmGroupCommonClassMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertySiriusXmGroupCommonClassBMember" name="LibertySiriusXmGroupCommonClassBMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertySirusXmGroupCommonClassCMember" name="LibertySirusXmGroupCommonClassCMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertyBravesGroupCommonClassMember" name="LibertyBravesGroupCommonClassMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertyBravesGroupCommonClassCMember" name="LibertyBravesGroupCommonClassCMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertyFormulaOneGroupCommonClassMember" name="LibertyFormulaOneGroupCommonClassMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="lmca_LibertyFormulaOneGroupCommonClassCMember" name="LibertyFormulaOneGroupCommonClassCMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>lmca-20210728_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://libertymedia.com/role/Cover" xlink:href="lmca-20210728.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://libertymedia.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassMember" xlink:label="loc_lmcaLibertySiriusXmGroupCommonClassMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySiriusXmGroupCommonClassMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassBMember" xlink:label="loc_lmcaLibertySiriusXmGroupCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySiriusXmGroupCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySirusXmGroupCommonClassCMember" xlink:label="loc_lmcaLibertySirusXmGroupCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySirusXmGroupCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassMember" xlink:label="loc_lmcaLibertyBravesGroupCommonClassMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyBravesGroupCommonClassMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassCMember" xlink:label="loc_lmcaLibertyBravesGroupCommonClassCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyBravesGroupCommonClassCMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassMember" xlink:label="loc_lmcaLibertyFormulaOneGroupCommonClassMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyFormulaOneGroupCommonClassMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassCMember" xlink:label="loc_lmcaLibertyFormulaOneGroupCommonClassCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyFormulaOneGroupCommonClassCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol_90" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName_90" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle_90" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation_90" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm_90" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_90" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_90" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers_90" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_90" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_90" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory_90" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness_90" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_90" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod_90" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard_90" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_90" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany_90" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat_90" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_90" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lmca-20210728_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassMember" xlink:label="lmca_LibertySiriusXmGroupCommonClassMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertySiriusXmGroupCommonClassMember" xlink:to="lmca_LibertySiriusXmGroupCommonClassMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertySiriusXmGroupCommonClassMember_lbl" xml:lang="en-US">Liberty Sirius Xm Group Common Class [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassBMember" xlink:label="lmca_LibertySiriusXmGroupCommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertySiriusXmGroupCommonClassBMember" xlink:to="lmca_LibertySiriusXmGroupCommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertySiriusXmGroupCommonClassBMember_lbl" xml:lang="en-US">Liberty Sirius Xm Group Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySirusXmGroupCommonClassCMember" xlink:label="lmca_LibertySirusXmGroupCommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertySirusXmGroupCommonClassCMember" xlink:to="lmca_LibertySirusXmGroupCommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertySirusXmGroupCommonClassCMember_lbl" xml:lang="en-US">Liberty Sirus Xm Group Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassMember" xlink:label="lmca_LibertyBravesGroupCommonClassMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertyBravesGroupCommonClassMember" xlink:to="lmca_LibertyBravesGroupCommonClassMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertyBravesGroupCommonClassMember_lbl" xml:lang="en-US">Liberty Braves Group Common Class [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassCMember" xlink:label="lmca_LibertyBravesGroupCommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertyBravesGroupCommonClassCMember" xlink:to="lmca_LibertyBravesGroupCommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertyBravesGroupCommonClassCMember_lbl" xml:lang="en-US">Liberty Braves Group Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassMember" xlink:label="lmca_LibertyFormulaOneGroupCommonClassMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertyFormulaOneGroupCommonClassMember" xlink:to="lmca_LibertyFormulaOneGroupCommonClassMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertyFormulaOneGroupCommonClassMember_lbl" xml:lang="en-US">Liberty Formula One Group Common Class [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassCMember" xlink:label="lmca_LibertyFormulaOneGroupCommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lmca_LibertyFormulaOneGroupCommonClassCMember" xlink:to="lmca_LibertyFormulaOneGroupCommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lmca_LibertyFormulaOneGroupCommonClassCMember_lbl" xml:lang="en-US">Liberty Formula One Group Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of Capitalization, Equity [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lmca-20210728_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://libertymedia.com/role/Cover" xlink:href="lmca-20210728.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://libertymedia.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapScheduleOfCapitalizationEquityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassMember" xlink:label="loc_lmcaLibertySiriusXmGroupCommonClassMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySiriusXmGroupCommonClassMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySiriusXmGroupCommonClassBMember" xlink:label="loc_lmcaLibertySiriusXmGroupCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySiriusXmGroupCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertySirusXmGroupCommonClassCMember" xlink:label="loc_lmcaLibertySirusXmGroupCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertySirusXmGroupCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassMember" xlink:label="loc_lmcaLibertyBravesGroupCommonClassMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyBravesGroupCommonClassMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyBravesGroupCommonClassCMember" xlink:label="loc_lmcaLibertyBravesGroupCommonClassCMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyBravesGroupCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassMember" xlink:label="loc_lmcaLibertyFormulaOneGroupCommonClassMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyFormulaOneGroupCommonClassMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lmca-20210728.xsd#lmca_LibertyFormulaOneGroupCommonClassCMember" xlink:label="loc_lmcaLibertyFormulaOneGroupCommonClassCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lmcaLibertyFormulaOneGroupCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2123478d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lmca="http://libertymedia.com/20210728"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lmca-20210728.xsd" xlink:type="simple"/>
    <context id="From2021-07-28to2021-07-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySiriusXmGroupCommonClassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySiriusXmGroupCommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertySirusXmGroupCommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyBravesGroupCommonClassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyBravesGroupCommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyFormulaOneGroupCommonClassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001560385</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lmca:LibertyFormulaOneGroupCommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-07-28to2021-07-28">0001560385</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-07-28to2021-07-28">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-07-28to2021-07-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-07-28to2021-07-28">2021-07-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-07-28to2021-07-28">LIBERTY MEDIA CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-07-28to2021-07-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-07-28to2021-07-28">001-35707</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-07-28to2021-07-28">37-1699499</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-07-28to2021-07-28">12300 Liberty Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-07-28to2021-07-28">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-07-28to2021-07-28">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-07-28to2021-07-28">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-07-28to2021-07-28">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-07-28to2021-07-28">875-5400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-07-28to2021-07-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-07-28to2021-07-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-07-28to2021-07-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-07-28to2021-07-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember">Series A Liberty SiriusXM Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember">LSXMA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember">Series B Liberty SiriusXM Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember">LSXMB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertySiriusXmGroupCommonClassBMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember">Series C Liberty SiriusXM Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember">LSXMK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertySirusXmGroupCommonClassCMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember">Series A Liberty Braves Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember">BATRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember">Series C Liberty Braves Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember">BATRK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertyBravesGroupCommonClassCMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember">Series A Liberty Formula One Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember">FWONA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember">Series C Liberty Formula One Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember">FWONK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-07-282021-07-28_custom_LibertyFormulaOneGroupCommonClassCMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-07-28to2021-07-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139804727048824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 28,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIBERTY
MEDIA CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001560385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">37-1699499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12300 Liberty Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">875-5400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassMember', window );">Liberty Sirius Xm Group Common Class [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series A Liberty SiriusXM Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LSXMA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassBMember', window );">Liberty Sirius Xm Group Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series B Liberty SiriusXM Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LSXMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySirusXmGroupCommonClassCMember', window );">Liberty Sirus Xm Group Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series C Liberty SiriusXM Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LSXMK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassMember', window );">Liberty Braves Group Common Class [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series A Liberty Braves Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BATRA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassCMember', window );">Liberty Braves Group Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series C Liberty Braves Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BATRK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassMember', window );">Liberty Formula One Group Common Class [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series A Liberty Formula One Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FWONA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassCMember', window );">Liberty Formula One Group Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series C Liberty Formula One Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FWONK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertySiriusXmGroupCommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertySirusXmGroupCommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertySirusXmGroupCommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertyBravesGroupCommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lmca_LibertyFormulaOneGroupCommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:_VWLM8BH&,+/LXWK/7WQ5J+D#VVAK5^-=;JMUAY3/0CPE<"US? ]0\%7-\
MU]\;<"U*+X"[7;J*\0T,=8.W4M<B</6E?PM1-S#4#?9%78N0-;Z!H6Y0C;J6
M^%9";V#0&QP*O8%!;[ W]%J47J#W-0'>>GGX5OY:!'2 (?X&AK_!OOAK$=H=
MX/K6RW;]PX4;HA_'92BF$Z7D'#?4O8KE;P&6.Y+/B_?O]UQ*GA2;,THB*O0)
MZOL)YW*]HU_I;WZ1<?$_4$L#!!0    ( +2=_5*?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( +2=_5('04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ M)W]4BV(X?'O    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ M)W]4IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " "TG?U2>T@A/=L%  "=(0  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ M)W]4I^@&_"Q @  X@P   T              ( !'PX  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " "TG?U2EXJ[',     3 @  "P
M@ '[$   7W)E;',O+G)E;'-02P$"% ,4    " "TG?U2JL0B%C,!   B @
M#P              @ 'D$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MM)W]4B0>FZ*M    ^ $  !H              ( !1!,  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ M)W]4F60>9(9 0  SP,  !,
M             ( !*10  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  <Q4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2123478d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://libertymedia.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2123478d1_8k.htm">tm2123478d1_8k.htm</File>
    <File>lmca-20210728.xsd</File>
    <File>lmca-20210728_def.xml</File>
    <File>lmca-20210728_lab.xml</File>
    <File>lmca-20210728_pre.xml</File>
    <File>tm2123478d1_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2123478d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 8,
   "dts": {
    "definitionLink": {
     "local": [
      "lmca-20210728_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2123478d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lmca-20210728_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lmca-20210728_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lmca-20210728.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 70,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 7,
   "memberStandard": 0,
   "nsprefix": "lmca",
   "nsuri": "http://libertymedia.com/20210728",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2123478d1_8k.htm",
      "contextRef": "From2021-07-28to2021-07-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://libertymedia.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2123478d1_8k.htm",
      "contextRef": "From2021-07-28to2021-07-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 7,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "lmca_LibertyBravesGroupCommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Braves Group Common Class C [Member]"
       }
      }
     },
     "localname": "LibertyBravesGroupCommonClassCMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertyBravesGroupCommonClassMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Braves Group Common Class [Member]"
       }
      }
     },
     "localname": "LibertyBravesGroupCommonClassMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertyFormulaOneGroupCommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Formula One Group Common Class C [Member]"
       }
      }
     },
     "localname": "LibertyFormulaOneGroupCommonClassCMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertyFormulaOneGroupCommonClassMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Formula One Group Common Class [Member]"
       }
      }
     },
     "localname": "LibertyFormulaOneGroupCommonClassMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertySiriusXmGroupCommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Sirius Xm Group Common Class B [Member]"
       }
      }
     },
     "localname": "LibertySiriusXmGroupCommonClassBMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertySiriusXmGroupCommonClassMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Sirius Xm Group Common Class [Member]"
       }
      }
     },
     "localname": "LibertySiriusXmGroupCommonClassMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "lmca_LibertySirusXmGroupCommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liberty Sirus Xm Group Common Class C [Member]"
       }
      }
     },
     "localname": "LibertySirusXmGroupCommonClassCMember",
     "nsuri": "http://libertymedia.com/20210728",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Capitalization, Equity [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://libertymedia.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-21-097779-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-097779-xbrl.zip
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MFE:UV.QE[D'3\-:%C @0ZQP18A\6N>RZ97>,/@61!R^H(;D5; #36G84K7L
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M+/I=*W*"@39G*@^Y%M7%5N"8TS#P@B2(5N_YR2H+L*YM.I$I+&"#!1--A1-
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M:Y]MIM7W/75:AT!J-0B^X5G&B(0WN"#+<N(;-N,+L15M>5)=49E/?].PV,R
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M!/]H!OKC2-SQ1\NJ"ZLQ%$N .7^# /ZAY->_D;@1_(&LMW,VD:F4@.()=BK
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M.R!Q3X4(OF(6Z]O?ND>6V>_MF=VN:>SIBFV?T2Z\_VDD&6.9MI'S?2_D*PV
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MNV9HF(%.27-$5'Z>#!H\DD&'\IH)H;->S"; 5L -V$<[G6I;YL#I8"9[#P^
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MJ'#D@.%!E=O(,M'Y)D@@.5./0-@UM$,E!\^!NJOY3T%F0]0C]S11<N*P&K,
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MKF,NB?,E4?MGSX_7> >]>LJ(+'.3@'6;?<NF?KQZ=A_NC9H&S[ V^^@&9GI
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MMB2MT2B/D-%Z@W/D&@=P]D>V) 0LJ6#:F41!BGRAB$JDVO(,SP T<8R<&@[
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M :: **!%HRSMUHO)04211E-J!3'YBHSG(YG&*+C1D-),C\F+X"AFDWCD=PU
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M9KODPJDI;WB_=PUW.%LPS8)V&UD6K219WN8NY1Q<Z!M=09#YE&FW:S(W$4G
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M,(9Q!,N?1XST?:4)7K/G38W0BI8SH#4L,F-T0I1,0#BKZ!/TRP).EYP1%PI
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M'2,1+$#X>4CU?S4T7YL8'TNT)@GQM)@HQ?L"PLO*I0I.=/7X&P@K6!_0[^*
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M\D=-#",QK8&2%:NA&IU!+7)FJLG./*=BK% 9+9>'V;_E?9>06#E^]&H9?G1
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M55L3.&&@_CR\B&8WZ-4*RC-=XW<)=(I&0N::_WT_"-BU\R"AL$Q+'.!0B-!
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M:<!U0?(HG@!!@ZK154MTTV.3N[@*R;3Z*!L_FF:CKU&)U-R]+LU*0%;ZI+%
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M/]S[BVCQP\FGC_#'_P=02P$"% ,4    " "TG?U2Z>G,1A $   4%   $0
M            @ $     ;&UC82TR,#(Q,#<R."YX<V102P$"% ,4    " "T
MG?U2!\,@X'X)  #*=@  %0              @ $_!   ;&UC82TR,#(Q,#<R
M.%]D968N>&UL4$L! A0#%     @ M)W]4IL(FH^'#   !)X  !4
M     ( !\ T  &QM8V$M,C R,3 W,CA?;&%B+GAM;%!+ 0(4 Q0    ( +2=
M_5(!Y(0AK @  %%Q   5              "  :H:  !L;6-A+3(P,C$P-S(X
M7W!R92YX;6Q02P$"% ,4    " "TG?U2\]/C>*4B  #NTP  $@
M    @ &)(P  =&TR,3(S-#<X9#%?.&LN:'1M4$L! A0#%     @ M)W]4B8_
MU,*^6   0V " !8              ( !7D8  '1M,C$R,S0W.&0Q7V5X,3 M
;,2YH=&U02P4&      8 !@", 0  4)\

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
